Matches in Wikidata for { <http://www.wikidata.org/entity/Q64635703> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64635703 description "clinical trial" @default.
- Q64635703 description "ensayu clínicu" @default.
- Q64635703 description "klinisch onderzoek" @default.
- Q64635703 description "клінічне випробування" @default.
- Q64635703 name "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis" @default.
- Q64635703 type Item @default.
- Q64635703 label "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis" @default.
- Q64635703 prefLabel "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis" @default.
- Q64635703 P1050 Q64635703-ECC089A7-5428-4BD1-9C64-284730E90D80 @default.
- Q64635703 P1132 Q64635703-6127A7D9-9411-4D46-B163-063C11BBBDF2 @default.
- Q64635703 P1476 Q64635703-AAD4F1E8-B314-44D9-975F-D02B51CCB9EA @default.
- Q64635703 P17 Q64635703-080D8EA4-0FD7-44FC-9B47-610DF98BE2EE @default.
- Q64635703 P17 Q64635703-0FA796BD-92E4-4FB9-AAC5-EA4F69611809 @default.
- Q64635703 P17 Q64635703-191AA2AD-8C92-40DD-AB32-F860724BB4CA @default.
- Q64635703 P17 Q64635703-5E4BAA54-B5D1-4F6E-AFF9-5B4B01B2BDF3 @default.
- Q64635703 P17 Q64635703-5FF4B26B-ACF6-4B4E-B499-DC8EB359612E @default.
- Q64635703 P17 Q64635703-646B1F40-08DB-4180-AB5A-4D8D248B7F6E @default.
- Q64635703 P17 Q64635703-BB35924A-18B8-4197-A800-3FD64DC6F241 @default.
- Q64635703 P17 Q64635703-BEFE123D-20FF-4D06-874F-1F464E077D77 @default.
- Q64635703 P17 Q64635703-C00289A0-F236-4BA6-B45F-A96A21179AF0 @default.
- Q64635703 P17 Q64635703-D0348AF6-C799-4878-B09E-4BC3BD365781 @default.
- Q64635703 P17 Q64635703-EB3C3C59-E524-4205-B763-E6972048AD36 @default.
- Q64635703 P17 Q64635703-EC0B5F9D-8E36-4180-A4B2-C2A47BC223DB @default.
- Q64635703 P17 Q64635703-F6A18C27-8E7C-4B72-A240-FA1A64B0A514 @default.
- Q64635703 P2899 Q64635703-FA601FD7-7317-4361-9BC9-EB65ED8B27E0 @default.
- Q64635703 P3098 Q64635703-D8C44B51-1A42-46B8-A06B-8071CBEDCE65 @default.
- Q64635703 P31 Q64635703-BB3A00E2-2BA6-453E-ACEA-9ACE36715381 @default.
- Q64635703 P4135 Q64635703-F691732F-6E29-4E60-B51E-E0B7094F234A @default.
- Q64635703 P580 Q64635703-40B46465-CF16-4522-B237-14C10A3E4C23 @default.
- Q64635703 P582 Q64635703-CE02982F-BDDB-44A9-AE59-783B3F8F0C88 @default.
- Q64635703 P6099 Q64635703-D2FD1E67-1F48-41DA-8062-E29E7DAEB4E6 @default.
- Q64635703 P8363 Q64635703-AB26572A-2B91-48EF-B0A7-2ACA87BF1243 @default.
- Q64635703 P1050 Q1344835 @default.
- Q64635703 P1132 "+515" @default.
- Q64635703 P1476 "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis" @default.
- Q64635703 P17 Q142 @default.
- Q64635703 P17 Q16 @default.
- Q64635703 P17 Q183 @default.
- Q64635703 P17 Q28 @default.
- Q64635703 P17 Q29 @default.
- Q64635703 P17 Q30 @default.
- Q64635703 P17 Q31 @default.
- Q64635703 P17 Q34 @default.
- Q64635703 P17 Q36 @default.
- Q64635703 P17 Q38 @default.
- Q64635703 P17 Q408 @default.
- Q64635703 P17 Q55 @default.
- Q64635703 P17 Q801 @default.
- Q64635703 P2899 "+18" @default.
- Q64635703 P3098 "NCT01788046" @default.
- Q64635703 P31 Q30612 @default.
- Q64635703 P4135 "+100" @default.
- Q64635703 P580 "2013-03-12T00:00:00Z" @default.
- Q64635703 P582 "2014-04-14T00:00:00Z" @default.
- Q64635703 P6099 Q42824827 @default.
- Q64635703 P8363 Q78089383 @default.